Suppr超能文献

通过调控Abca3基因诱导的表面活性剂失调小鼠模型中的异常肺重塑。

Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene.

作者信息

Beers Michael F, Knudsen Lars, Tomer Yaniv, Maronn Julian, Zhao Ming, Ochs Matthias, Mulugeta Surafel

机构信息

Pulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States.

Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany; Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.

出版信息

Ann Anat. 2017 Mar;210:135-146. doi: 10.1016/j.aanat.2016.11.015. Epub 2016 Dec 26.

Abstract

The lipid transporter, ATP binding cassette class A3 (ABCA3), plays a critical role in the biogenesis of alveolar type 2 (AT2) cell lamellar bodies (LBs). A relatively large number of mutations in the ABCA3 gene have been identified in association with diffuse parenchymal lung disease (DPLD), the most common of which is a missense mutation (valine substitution for lysine at residue 292 (ABCA3)) that leads to functional impairment of the transporter in vitro. The consequences of ABCA3 gene expression in vivo are unknown. To address this question, we developed mouse models expressing ABCA3 knocked-in to the endogenous mouse locus. The parental (F1) mouse line (mAbca3) that retained an intronic pgk-Neo selection cassette (inserted in reverse orientation) (mAbca3-rNeo) demonstrated an allele dependent extracellular surfactant phospholipid (PL) deficiency. We hypothesize that this PL deficiency leads to aberrant parenchymal remodeling contributing to the pathophysiology of the DPLD phenotype. Compared to wild type littermates, baseline studies of mice homozygous for the pgk-Neo insert (mAbca3-rNeo) revealed nearly 50% reduction in bronchoalveolar lavage (BAL) PL content that was accompanied by quantitative reduction in AT2 LB size with a compensatory increase in LB number. The phenotypic alteration in surfactant lipid homeostasis resulted in an early macrophage predominant alveolitis which peaked at 8 weeks of age. This was followed by age-dependent development of histological DPLD characterized initially by peribronchial inflammatory cell infiltration and culminating in both an emphysema-like phenotype (which included stereologically quantifiable reductions in both alveolar septal surface area and volume of septal wall tissue) plus foci of trichrome-positive collagen deposition together with substantial proliferation of hyperplastic AT2 cells. In addition to spontaneous lung remodeling, mABCA3-rNeo mice were rendered more vulnerable to exogenous injury. Three weeks following intratracheal bleomycin challenge, mAbca3-rNeo mice demonstrated allele-dependent susceptibility to bleomycin including enhanced weight loss, augmented airspace destruction, and increased fibrosis. Removal of the rNeo cassette from mAbca3 alleles resulted in restoration of BAL PL content to wild-type levels and an absence of changes in lung histology up to 32 weeks of age. These results support the importance of surfactant PL homeostasis as a susceptibility factor for both intrinsic and exogenously induced lung injury/remodeling.

摘要

脂质转运蛋白ATP结合盒A3类(ABCA3)在2型肺泡(AT2)细胞板层小体(LB)的生物合成中起关键作用。已发现ABCA3基因中存在相对大量的与弥漫性肺实质疾病(DPLD)相关的突变,其中最常见的是错义突变(第292位残基处缬氨酸替代赖氨酸(ABCA3)),该突变在体外导致转运蛋白功能受损。ABCA3基因在体内表达的后果尚不清楚。为了解决这个问题,我们构建了将ABCA3敲入内源性小鼠基因座的小鼠模型。保留内含子pgk - Neo选择盒(以反向插入)的亲代(F1)小鼠品系(mAbca3)(mAbca3 - rNeo)表现出等位基因依赖性细胞外表面活性物质磷脂(PL)缺乏。我们推测这种PL缺乏会导致实质重塑异常,从而促成DPLD表型的病理生理学。与野生型同窝小鼠相比,对pgk - Neo插入纯合的小鼠(mAbca3 - rNeo)的基线研究显示支气管肺泡灌洗(BAL)PL含量降低了近50%,同时AT2 LB大小定量减少,LB数量代偿性增加。表面活性物质脂质稳态的表型改变导致早期以巨噬细胞为主的肺泡炎,在8周龄时达到峰值。随后是年龄依赖性的组织学DPLD发展,最初表现为支气管周围炎性细胞浸润,最终导致肺气肿样表型(包括肺泡间隔表面积和间隔壁组织体积在立体定量上的减少)以及三色染色阳性的胶原沉积灶,同时伴有增生性AT2细胞的大量增殖。除了自发性肺重塑外,mABCA3 - rNeo小鼠对外源性损伤更敏感。气管内注射博来霉素攻击3周后,mAbca3 - rNeo小鼠表现出等位基因依赖性的博来霉素易感性,包括体重减轻加剧、气腔破坏增加和纤维化增加。从mAbca3等位基因中去除rNeo盒可使BAL PL含量恢复到野生型水平,并且在32周龄之前肺组织学无变化。这些结果支持表面活性物质PL稳态作为内在和外源性诱导的肺损伤/重塑的易感性因素的重要性。

相似文献

1
Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene.
Ann Anat. 2017 Mar;210:135-146. doi: 10.1016/j.aanat.2016.11.015. Epub 2016 Dec 26.
2
The common ABCA3 variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling.
Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L291-L307. doi: 10.1152/ajplung.00400.2020. Epub 2021 Jun 16.
3
Surfactant composition and function in patients with ABCA3 mutations.
Pediatr Res. 2006 Jun;59(6):801-5. doi: 10.1203/01.pdr.0000219311.14291.df. Epub 2006 Apr 26.
4
Alveolar injury and regeneration following deletion of ABCA3.
JCI Insight. 2017 Dec 21;2(24):97381. doi: 10.1172/jci.insight.97381.
6
Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice.
Am J Physiol Lung Cell Mol Physiol. 2010 May;298(5):L646-59. doi: 10.1152/ajplung.00409.2009. Epub 2010 Feb 26.
7
8
Respiratory syncytial virus potentiates ABCA3 mutation-induced loss of lung epithelial cell differentiation.
Hum Mol Genet. 2012 Jun 15;21(12):2793-806. doi: 10.1093/hmg/dds107. Epub 2012 Mar 20.
9
ABCA3 protects alveolar epithelial cells against free cholesterol induced cell death.
Biochim Biophys Acta. 2015 Jul;1851(7):987-95. doi: 10.1016/j.bbalip.2015.03.004. Epub 2015 Mar 25.
10
ABCA3 as a lipid transporter in pulmonary surfactant biogenesis.
J Biol Chem. 2007 Mar 30;282(13):9628-9634. doi: 10.1074/jbc.M611767200. Epub 2007 Jan 30.

引用本文的文献

1
Targeting alveolar epithelial cell metabolism in pulmonary fibrosis: Pioneering an emerging therapeutic strategy.
Front Cell Dev Biol. 2025 Jun 25;13:1608750. doi: 10.3389/fcell.2025.1608750. eCollection 2025.
2
Lung repair and regeneration: Advanced models and insights into human disease.
Cell Stem Cell. 2024 Apr 4;31(4):439-454. doi: 10.1016/j.stem.2024.02.009. Epub 2024 Mar 15.
4
ABCA3-related interstitial lung disease beyond infancy.
Thorax. 2023 Jun;78(6):587-595. doi: 10.1136/thorax-2022-219434. Epub 2023 Feb 20.
5
Metabolic reprogramming of pulmonary fibrosis.
Front Pharmacol. 2022 Nov 14;13:1031890. doi: 10.3389/fphar.2022.1031890. eCollection 2022.
6
Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.
Free Neuropathol. 2021;2:33. doi: 10.17879/freeneuropathology-2021-3528. Epub 2021 Dec 13.
7
The common ABCA3 variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling.
Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L291-L307. doi: 10.1152/ajplung.00400.2020. Epub 2021 Jun 16.
8
Genetic disorders of the surfactant system: focus on adult disease.
Eur Respir Rev. 2021 Feb 16;30(159). doi: 10.1183/16000617.0085-2020. Print 2021 Mar 31.
9
Senescence in Pulmonary Fibrosis: Between Aging and Exposure.
Front Med (Lausanne). 2020 Nov 12;7:606462. doi: 10.3389/fmed.2020.606462. eCollection 2020.
10
Mechanical ventilation-induced alterations of intracellular surfactant pool and blood-gas barrier in healthy and pre-injured lungs.
Histochem Cell Biol. 2021 Feb;155(2):183-202. doi: 10.1007/s00418-020-01938-x. Epub 2020 Nov 13.

本文引用的文献

1
The biology of the ABCA3 lipid transporter in lung health and disease.
Cell Tissue Res. 2017 Mar;367(3):481-493. doi: 10.1007/s00441-016-2554-z. Epub 2016 Dec 26.
3
ABCA3 mutations led to pulmonary fibrosis and emphysema with pulmonary hypertension in an 8-year-old girl.
Pediatr Pulmonol. 2016 Jun;51(6):E21-3. doi: 10.1002/ppul.23379. Epub 2016 Jan 18.
4
Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects.
Clin Med Insights Circ Respir Pulm Med. 2015 Oct 11;9(Suppl 1):57-68. doi: 10.4137/CCRPM.S23282. eCollection 2015.
7
Interstitial lung disease.
Eur Respir Rev. 2014 Mar 1;23(131):40-54. doi: 10.1183/09059180.00009113.
8
NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis.
PLoS One. 2014 Jan 21;9(1):e85722. doi: 10.1371/journal.pone.0085722. eCollection 2014.
9
Null ABCA3 in humans: large homozygous ABCA3 deletion, correlation to clinical-pathological findings.
Pediatr Pulmonol. 2014 Mar;49(3):E116-20. doi: 10.1002/ppul.22983. Epub 2014 Jan 14.
10
Novel ABCA3 mutations as a cause of respiratory distress in a term newborn.
Gene. 2014 Jan 25;534(2):417-20. doi: 10.1016/j.gene.2013.11.015. Epub 2013 Nov 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验